These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 22428977)

  • 1. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.
    Aurnhammer C; Haase M; Muether N; Hausl M; Rauschhuber C; Huber I; Nitschko H; Busch U; Sing A; Ehrhardt A; Baiker A
    Hum Gene Ther Methods; 2012 Feb; 23(1):18-28. PubMed ID: 22428977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel qPCR strategy for quantification of recombinant adeno-associated virus serotype 2 vector genome-titer].
    Meng Q; Zhang B; Zhang C
    Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):235-42. PubMed ID: 23697168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System.
    Savy A; Dickx Y; Nauwynck L; Bonnin D; Merten OW; Galibert L
    Hum Gene Ther Methods; 2017 Oct; 28(5):277-289. PubMed ID: 28967288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
    Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
    Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.
    Wang Y; Ling C; Song L; Wang L; Aslanidi GV; Tan M; Ling C; Srivastava A
    Hum Gene Ther Methods; 2012 Aug; 23(4):225-33. PubMed ID: 22966785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
    Yan Z; Zak R; Zhang Y; Engelhardt JF
    J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
    Wang XS; Ponnazhagan S; Srivastava A
    J Virol; 1996 Mar; 70(3):1668-77. PubMed ID: 8627687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
    Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
    J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method for the quantification of adeno-associated virus vectors for RNA interference applications using quantitative polymerase chain reaction and purified genomic adeno-associated virus DNA as a standard.
    Wagner A; Röhrs V; Kedzierski R; Fechner H; Kurreck J
    Hum Gene Ther Methods; 2013 Dec; 24(6):355-63. PubMed ID: 23987130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PCR-amplified transgene fragment flanked by a single copy of a truncated inverted terminal repeat for recombinant adeno-associated virus production prevents unnecessary plasmid DNA packaging.
    Adachi K; Tomono T; Okada H; Shiozawa Y; Yamamoto M; Miyagawa Y; Okada T
    Gene Ther; 2022 Aug; 29(7-8):449-457. PubMed ID: 34629464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the B-B' and C-C' regions of inverted terminal repeats reduces rAAV productivity but increases transgene expression.
    Zhou Q; Tian W; Liu C; Lian Z; Dong X; Wu X
    Sci Rep; 2017 Jul; 7(1):5432. PubMed ID: 28710345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes.
    Chiorini JA; Afione S; Kotin RM
    J Virol; 1999 May; 73(5):4293-8. PubMed ID: 10196327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virus.
    Mroske C; Rivera H; Ul-Hasan T; Chatterjee S; Wong KK
    Hum Gene Ther Methods; 2012 Apr; 23(2):128-36. PubMed ID: 22612656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
    Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
    J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.
    Thomas CE; Storm TA; Huang Z; Kay MA
    J Virol; 2004 Mar; 78(6):3110-22. PubMed ID: 14990730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
    Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping of AAV plasmid stocks: quality control in adeno-associated virus vector production.
    Schmitt M; Pawlita M; Kleinschmidt J
    J Mol Microbiol Biotechnol; 2010; 19(4):204-12. PubMed ID: 21088429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.
    Hewitt FC; Li C; Gray SJ; Cockrell S; Washburn M; Samulski RJ
    J Virol; 2009 Apr; 83(8):3919-29. PubMed ID: 19211760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.